X-153982090-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003492.3(TMEM187):c.28G>A(p.Val10Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000908 in 1,211,835 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_003492.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM187 | NM_003492.3 | c.28G>A | p.Val10Met | missense_variant | 2/2 | ENST00000369982.5 | NP_003483.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM187 | ENST00000369982.5 | c.28G>A | p.Val10Met | missense_variant | 2/2 | 1 | NM_003492.3 | ENSP00000358999.4 | ||
TMEM187 | ENST00000425274.1 | c.28G>A | p.Val10Met | missense_variant | 2/2 | 5 | ENSP00000390108.1 | |||
TMEM187 | ENST00000431598.1 | c.28G>A | p.Val10Met | missense_variant | 2/2 | 3 | ENSP00000412872.1 |
Frequencies
GnomAD3 genomes AF: 0.0000176 AC: 2AN: 113689Hom.: 0 Cov.: 25 AF XY: 0.0000279 AC XY: 1AN XY: 35807
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 182085Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 66941
GnomAD4 exome AF: 0.00000820 AC: 9AN: 1098094Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363514
GnomAD4 genome AF: 0.0000176 AC: 2AN: 113741Hom.: 0 Cov.: 25 AF XY: 0.0000279 AC XY: 1AN XY: 35869
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 04, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at